University of Dundee

Start-ups & Spin-outs

We have a successful record in launching spin-out companies which has helped drive the establishment of a life sciences cluster which makes a major contribution to the Tay Cities regional economy.

  • Developing drugs using ground-breaking targeted protein degradation technology from the laboratory of Professor Alessio Ciulli. It is backed by Advent Life Sciences, one of the leading trans-Atlantic venture capital investors. 

  • Developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.

  • DC Biosciences Ltd provides pharmaceutical and biotech companies with proteomics services to accelerate the development of safer drugs.

  • Exscientia's goal is to revolutionize productivity by the use of data analytics and machine learning in drug design and pharmacogenomics.

  • Design and production of software and data storage solutions for biological imaging. Glencoe Software is the commercial arm of the Open Microscopy Environment, a community-led, open source data specification and software development consortium.

  • Offers drug discovery services as hit identification, confirmation and validation.

  • Developing powerful new software solutions for managing complex informatics and multidimensional proteomics scientific datasets in a wide range of laboratory and industrial environments.

  • Enables and supports ubiquitin system focused drug discovery by developing novel compounds targeted towards ubiquitin system proteins as well providing access to a suite of comprehensive research services and reagents.